Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0827

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis ; day:17 ; month:2 ; year:2018 ; pages:1-11
Calcified tissue international ; (17.2.2018), 1-11

Keyword: Krebs
Onkologie

Creator: Marino, Silvia

Contributor: Bishop, Ryan T.
Mollat, Patrick
Idris, Aymen I.
SpringerLink (Online service)

DOI: 10.1007/s00223-018-0406-4

URN: urn:nbn:de:1111-2018040829583

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Marino, Silvia
Bishop, Ryan T.
Mollat, Patrick
Idris, Aymen I.
SpringerLink (Online service)

Other Objects (12)

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke

Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo

Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

Hochschulschrift

Cellular pharmacological inhibition of enveloped virus entry

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke

Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo

Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

Hochschulschrift

Cellular pharmacological inhibition of enveloped virus entry

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke

Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo

Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

Hochschulschrift

Cellular pharmacological inhibition of enveloped virus entry

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke

Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo

Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

Cellular pharmacological inhibition of enveloped virus entry

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke

Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo

Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

Cellular pharmacological inhibition of enveloped virus entry

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke

Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo

Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer

Cellular pharmacological inhibition of enveloped virus entry

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage

Related objects

Reset password